WAIVER – CONVERTIBLE NOTEWaiver – Convertible Note • March 19th, 2010 • Oxygen Biotherapeutics, Inc. • Services-commercial physical & biological research
Contract Type FiledMarch 19th, 2010 Company IndustryThis Waiver is given with respect to the Convertible Note Due January 2013 identified at the foot of this Waiver (the “Note”), by the person whose signature appears at the foot of this Waiver, who is the holder of the Note (the “Holder”), to Oxygen Biotherapeutics, Inc., a Delaware corporation (the “Company”). The Company is the successor to Synthetic Blood International, Inc., a New Jersey corporation, which originally issued the Note. Capitalized terms used herein that are not otherwise defined shall have the meaning ascribed to such terms in the Warrant.